Rongxin X. He
#88 Jiefang Road
Hangzhou, 310001, China
Hangzhou, 310001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Whole-body reduced-dose dual-energy CT with deep learning image reconstruction for detection of osteolytic lesions in multiple myeloma.
Journal: Radiography (London, England : 1995)
Published: January 01, 2026
Application of robot-assisted posterolateral approach in complex primary total hip arthroplasty
Journal: Zhonghua wai ke za zhi [Chinese journal of surgery]
Published: July 30, 2025
Diagnostic Value of Pericruciate Fat Pad Measurement by MRI in Patients With Knee Articular Cartilage Injury.
Journal: British journal of hospital medicine (London, England : 2005)
Published: April 23, 2025
Cirsilineol inhibits RANKL-induced osteoclast activity and ovariectomy-induced bone loss via NF-κb/ERK/p38 signaling pathways.
Journal: Chinese medicine
Published: January 08, 2024
Therapeutic potential of mesenchymal stem cell-derived exosomes in skeletal diseases.
Journal: Frontiers in molecular biosciences
Published: July 27, 2023
Identification of hub genes and therapeutic drugs in osteonecrosis of the femoral head through integrated bioinformatics analysis and literature mining.
Journal: Scientific reports
Published: March 27, 2023
Rejuvenation of tendon stem/progenitor cells for functional tendon regeneration through platelet-derived exosomes loaded with recombinant Yap1.
Journal: Acta biomaterialia
Published: September 10, 2022
Prussian Blue Nanozyme Normalizes Microenvironment to Delay Osteoporosis.
Journal: Advanced healthcare materials
Published: April 07, 2022
Anethole inhibits RANKL-induced osteoclastogenesis by downregulating ERK/AKT signaling and prevents ovariectomy-induced bone loss in vivo.
Journal: International immunopharmacology
Published: May 07, 2021
Partial two-stage exchange: an alternative method for infected total hip arthroplasty.
Journal: BMC musculoskeletal disorders
Published: March 30, 2021
Isoalantolactone inhibits RANKL-induced osteoclast formation via multiple signaling pathways.
Journal: International immunopharmacology
Published: February 24, 2020
Last Updated: 09/26/2026